Drotrecogin alfa (activated) for severe sepsis
Maglio, D.
Connecticut Medicine 66(3): 145-150
2002
ISSN/ISBN: 0010-6178 PMID: 11957766 Document Number: 544405
Document emailed within 1 workday
Related Documents
Macias, W.L.; Yan, S.B.; Grinnell, B.W. 2004: The development of drotrecogin alfa (activated) for the treatment of severe sepsis International Journal of Artificial Organs 27(5): 360-370Liang, J.; Streat, S.; Torrance, J.; Sleigh, J.; Freebairn, R.; Ramsay, M. 2003: Drotrecogin alfa (recombinant human activated protein C) in severe sepsis--a New Zealand viewpoint New Zealand Medical Journal 116(1181): U586
Lai, P.S.; Matteau, A.; Iddriss, A.; Hawes, J.C.L.; Ranieri, V.; Thompson, B.T. 2013: An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock Minerva Anestesiologica 79(1): 33-43
Albuali, W.H.; Singh, R.N.; Fraser, D.D.; Scott, L.A.; Kornecki, A. 2005: Drotrecogin alfa (activated) treatment in a neonate with sepsis and multi organ failure Saudi Medical Journal 26(8): 1289-1292
Gøtzsche, P.C. 2013: There is no effect of drotrecogin alfa in severe sepsis Ugeskrift for Laeger 175(13): 903
Bartelink, A.K.M. 2006: Questionable efficacy and safety of activated drotrecogin alpha (activated protein C) in the treatment of severe sepsis Nederlands Tijdschrift Voor Geneeskunde 150(7): 352-354
Banks, S.M.; Gerstenberger, E.; Eichacker, P.Q.; Natanson, C. 2003: Long-term cost effectiveness of drotrecogin alfa (activated): an unanswered question Critical Care Medicine 31(1): 308-309
Taylor, B.; Burns, D.; van de Wal, B.W.; MBewu, T.; Keeton, G.R. 2003: Should health care money in South Africa be spent on drotrecogin alfa? South African Medical Journal 93(7): 500-501
Mahabeer, N.; Zwaal, J. 2005: Activated protein C in a pregnant patient with severe sepsis Hospital Medicine 66(2): 124
Ruangchan, S.; Chusri, S.; Saengsanga, P.; Kiamkan, N.; Phunpairoth, P.; Chayakul, P. 2016: Clinical Outcomes of Community-Acquired Severe Sepsis after Implementation of a Simple Severe Sepsis Fast Track Journal of the Medical Association of Thailand 99(8): 877-885
Brun-Buisson, C.; Doyon, F.; Carlet, J.; Dellamonica, P.; Gouin, F.; Lepoutre, A.; Mercier, J.C.; Offenstadt, G.; Régnier, B. 1995: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. a multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis JAMA 274(12): 968-974
Aikawa, N. 2011: Revised Surviving Sepsis Campaign Guidelines and therapy for severe sepsis Japanese Journal of Antibiotics 64(1): 37-44
McMenamin, L.; Murch, N.; Daniels, R. 2013: Severe sepsis, social media and the #Sepsis 6: 'Tweeting' national innovations Acute Medicine 12(2): 83-88
González de Dios, J.; Moya Benavent, M.; Herranz Sánchez, Y.; Juste Ruiz, M.; González Montero, R. 1996: The interferon alfa-2a treatment of the severe form of the Kasabach-Merritt syndrome with neonatal onset Anales Espanoles de Pediatria 44(2): 179-183
Sznol, M.; Clark, J.W.; Smith, J.W.; Steis, R.G.; Urba, W.J.; Rubinstein, L.V.; VanderMolen, L.A.; Janik, J.; Sharfman, W.H.; Fenton, R.G. 1992: Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma Journal of the National Cancer Institute 84(12): 929-937
Nevens, F.; Van Vlierberghe, H.; D'Heygere, E.; Delwaide, J.; Adler, M.; Henrion, J.; Lenaerts, A.; Hendlisz, A.; Michielsen, P.; Bastens, B.; Brenard, R.; Laureys, A. 2010: A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients Acta Gastro-Enterologica Belgica 73(2): 223-228
Wong, J. B.; Nevens, F. 2002: Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium Acta Gastro-Enterologica Belgica 65(2): 110-111
Fernández, I.; Castellano, G.; Canga, F.; Colina, F.; García, H.; Fuertes, A.; Casis, B.; Martín, A.; Solís, J.A. 1995: A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C Gastroenterologia y Hepatologia 18(2): 66-72
Baumgartner, J.D.; Heumann, D. 1993: Cytokines and severe sepsis La Revue du Praticien 43(5): 559-563
Mozzillo, N.; Ottaviano, A.; Formato, A.; Forestieri, P.; Bucci, L. 1985: Severe abdominal sepsis Minerva Chirurgica 40(7): 387-388